Viewing StudyNCT00078585



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00078585
Status: COMPLETED
Last Update Posted: 2017-09-11
First Post: 2004-03-01

Brief Title: PROSTVAC-VFTRICOM Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
Sponsor: Bavarian Nordic
Organization: Bavarian Nordic

Organization Data

Organization: Bavarian Nordic
Class: INDUSTRY
Study ID: TBC-PRO-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Bavarian Nordic
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH
Therion Biologics Corporation INDUSTRY